| scholarly article | Q13442814 |
| P50 | author | Cynthia S Crowson | Q87215892 |
| P2093 | author name string | Eric L Matteson | |
| Sherine E Gabriel | |||
| Bharath Manu Akkara Veetil | |||
| Elena Myasoedova | |||
| P2860 | cites work | Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III) | Q27860959 |
| Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report | Q27861020 | ||
| Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) | Q29547825 | ||
| EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis | Q33505914 | ||
| The delivery of evidence-based preventive care for older Americans with arthritis | Q34153010 | ||
| History of the Rochester Epidemiology Project | Q34374377 | ||
| Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment--a prospective, controlled study | Q34897630 | ||
| Preventive medical services among patients with rheumatoid arthritis. | Q35216076 | ||
| Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis | Q35553035 | ||
| Patterns of cardiovascular risk in rheumatoid arthritis | Q35638493 | ||
| Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis | Q35638659 | ||
| Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis | Q35954510 | ||
| Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. | Q36031031 | ||
| Modulation of lipoprotein plasma concentrations during long-term anti-TNF therapy in patients with active rheumatoid arthritis | Q36204149 | ||
| By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? | Q36884264 | ||
| The Rochester Epidemiology Project: exploiting the capabilities for population-based research in rheumatic diseases | Q37027093 | ||
| Lipid profiles in patients with rheumatoid arthritis: mechanisms and the impact of treatment | Q37131883 | ||
| Interpreting lipid levels in the context of high-grade inflammatory states with a focus on rheumatoid arthritis: a challenge to conventional cardiovascular risk actions | Q37415092 | ||
| Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis | Q37977885 | ||
| Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? | Q43255462 | ||
| Underidentification and undertreatment of dyslipidemia | Q44305605 | ||
| The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: a meta-analysis | Q44882366 | ||
| Initiation and adherence to secondary prevention pharmacotherapy after myocardial infarction in patients with rheumatoid arthritis: a nationwide cohort study | Q45730150 | ||
| Lipid profiles among US elderly with untreated rheumatoid arthritis--the Third National Health and Nutrition Examination Survey. | Q46838483 | ||
| Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity | Q73986445 | ||
| Lipid profiles in untreated patients with rheumatoid arthritis | Q78139431 | ||
| Indications for lowering LDL cholesterol in rheumatoid arthritis: an unrecognized problem | Q79918765 | ||
| Is the "lipid paradox" in rheumatoid arthritis really a paradox? Comment on the article by Bartels et al | Q84745276 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| P304 | page(s) | 1082-1088 | |
| P577 | publication date | 2013-05-01 | |
| P1433 | published in | The Journal of Rheumatology | Q7743623 |
| P1476 | title | Use of lipid-lowering agents in rheumatoid arthritis: a population-based cohort study | |
| P478 | volume | 40 |
| Q47859328 | Cardiovascular risk management in rheumatoid arthritis patients still suboptimal: the Implementation of Cardiovascular Risk Management in Rheumatoid Arthritis project |
| Q39662558 | Drug prescribing trends in adults with rheumatoid arthritis: a population-based comparative study from 2005 to 2014. |
| Q26748085 | Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist |
| Q38844078 | Implementing an Electronic Medical Record-Based Reminder for Cardiovascular Risk Screening in Rheumatoid Arthritis. |
| Q52312175 | Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications. |
| Q35763883 | Management of hyperlipidemia among patients with rheumatoid arthritis in the primary care setting. |
| Q27694518 | Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations |
| Q39082330 | Primary Care Screening and Comorbidity Management in Rheumatoid Arthritis in Ontario, Canada. |
| Q89121860 | Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis |
| Q36001551 | Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative |
Search more.